Exactech entered into a long-term strategic agreement with RTI Surgical related to the development and supply of biologic bone substitutes.
As part of the agreement, RTI Surgical has acquired Exactech’s Optecure® demineralized bone matrix for use as a bone graft extender in the spine, pelvis and extremities. Optecure will complement RTI Surgical’s portfolio of bone graft substitutes.
“Biologic materials that support joint replacement surgery are an important facet of Exactech’s business,” said Exactech CEO Darin Johnson. “This collaboration with RTI allows each company to focus on our unique strengths. RTI has specialized expertise in the procurement, processing and manufacturing of human-derived tissue-based implants and Exactech markets and distributes the clinical solutions to help surgeons treat patients. We are pleased that this deal strengthens our long-standing partnership and positions us to have a more stable supply to support our selling efforts.”
Exactech entered into a long-term strategic agreement with RTI Surgical related to the development and supply of biologic bone substitutes.
As part of the agreement, RTI Surgical has acquired Exactech's Optecure® demineralized bone matrix for use as a bone graft extender in the spine, pelvis and extremities. Optecure will complement RTI...
Exactech entered into a long-term strategic agreement with RTI Surgical related to the development and supply of biologic bone substitutes.
As part of the agreement, RTI Surgical has acquired Exactech’s Optecure® demineralized bone matrix for use as a bone graft extender in the spine, pelvis and extremities. Optecure will complement RTI Surgical’s portfolio of bone graft substitutes.
“Biologic materials that support joint replacement surgery are an important facet of Exactech’s business,” said Exactech CEO Darin Johnson. “This collaboration with RTI allows each company to focus on our unique strengths. RTI has specialized expertise in the procurement, processing and manufacturing of human-derived tissue-based implants and Exactech markets and distributes the clinical solutions to help surgeons treat patients. We are pleased that this deal strengthens our long-standing partnership and positions us to have a more stable supply to support our selling efforts.”
Copy to clipboard 
